Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $168.79 million. The enterprise value is $54.44 million.
Important Dates
The last earnings date was Wednesday, March 11, 2026, before market open.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMT has 32.59 million shares outstanding. The number of shares has increased by 3.17% in one year.
| Current Share Class | 32.02M |
| Shares Outstanding | 32.59M |
| Shares Change (YoY) | +3.17% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 44.78% |
| Float | 29.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.82, with a Debt / Equity ratio of 0.00.
| Current Ratio | 22.82 |
| Quick Ratio | 22.18 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.20% and return on invested capital (ROIC) is -26.60%.
| Return on Equity (ROE) | -38.20% |
| Return on Assets (ROA) | -25.70% |
| Return on Invested Capital (ROIC) | -26.60% |
| Return on Capital Employed (ROCE) | -51.08% |
| Weighted Average Cost of Capital (WACC) | 22.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.65M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.43% in the last 52 weeks. The beta is 3.40, so SGMT's price volatility has been higher than the market average.
| Beta (5Y) | 3.40 |
| 52-Week Price Change | +37.43% |
| 50-Day Moving Average | 5.73 |
| 200-Day Moving Average | 7.05 |
| Relative Strength Index (RSI) | 40.94 |
| Average Volume (20 Days) | 364,193 |
Short Selling Information
The latest short interest is 3.66 million, so 11.23% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 3.89M |
| Short % of Shares Out | 11.23% |
| Short % of Float | 12.21% |
| Short Ratio (days to cover) | 4.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -56.89M |
| Pretax Income | -51.04M |
| Net Income | -51.04M |
| EBITDA | n/a |
| EBIT | -56.89M |
| Earnings Per Share (EPS) | -$1.58 |
Full Income Statement Balance Sheet
The company has $113.12 million in cash and $78,000 in debt, with a net cash position of $113.05 million or $3.47 per share.
| Cash & Cash Equivalents | 113.12M |
| Total Debt | 78,000 |
| Net Cash | 113.05M |
| Net Cash Per Share | $3.47 |
| Equity (Book Value) | 111.38M |
| Book Value Per Share | 3.42 |
| Working Capital | 111.30M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -45.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SGMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.17% |
| Shareholder Yield | -3.17% |
| Earnings Yield | -30.47% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SGMT is $27.00, which is 421.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.00 |
| Price Target Difference | 421.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.29% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |